Search Results - "BASARAN, Gul Atalay"

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer by BURZYKOWSKI, Tomasz, BUYSE, Marc, JASSEM, Jacek, BONTENBAL, Marijke, BONNETERRE, Jacques, STEPHEN CHAN, BASARAN, Gul Atalay, THERASSE, Patrick, PICCART-GEBHART, Martine J, SLEDGE, George, CARMICHAEL, James, LÜCK, Hans-Joachim, MACKEY, John R, NABHOLTZ, Jean-Marc, PARIDAENS, Robert, BIGANZOLI, Laura

“…Overall survival (OS) can be observed only after prolonged follow-up, and any potential effect of first-line therapies on OS may be confounded by the effects…”
Get full text

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer by PICCART-GEBHART, Martine J, BURZYKOWSKI, Tomasz, JASSEM, Jacek, BONTENBAL, Marijke, BONNETERRE, Jacques, CHAN, Stephen, BASARAN, Gul Atalay, THERASSE, Patrick, BUYSE, Marc, SLEDGE, George, CARMICHAEL, James, LÜCK, Hans-Joachim, MACKEY, John R, NABHOLTZ, Jean-Marc, PARIDAENS, Robert, BIGANZOLI, Laura

“…Taxanes (paclitaxel or docetaxel) have been sequenced or combined with anthracyclines (doxorubicin or epirubicin) for the first-line treatment of advanced…”
Get full text

Clinical Outcome of Rhabdomyosarcoma in Adolescent and Adult Patients: Single Center Experience from Turkey by Ustuner, Zeki, Basaran, Mert, Dizdar, Yavuz, Agaoglu, Fulya Yaman, Bilgic, Bilge, Sakar, Burak, Basaran, Gul Atalay, Darendeliler, Emin, Ozger, Harzem, Onat, Haluk, Bavbek, Sevil

“…Rhabdomyosarcoma (RMS) is rare disease in adults (age ≥ 16 years). The data from randomized prospective trials are scarce; the clinical outcome of these…”
Get full text

Clinical and pathologic characteristics of patients with breast cancer and a second non-breast primary tumor by Atalay Basaran, Gul, Yazar, Aziz, Uras, Cihan, Tezcanli, Evrim, Cabuk, Devrim, Atalar, Banu, Ozyar, Enis

“…Abstract only e11539 Background: We aimed to investigate the clinical and pathologic characteristics of patients with breast cancer (BC) who had a non-breast…”
Get full text

Hormana duyarlı meme kanserinde EGFR (Her-1) ve EGFR sinyal Ileti yolunda yer alan alt yol proteinlerinin ekspresyon biçimi ve bu ekspresyonun endokrin tedaviye yanıt süresi Ile Ilişkisi by Başaran, Gül Atalay

“…Endokrin tedavi reseptör pozitif meme kanseri hastalarının tedavisinde önemli bir tedavi biçimidir. Ancak reseptör pozitif tüm hastalar endokrin tedaviden…”
Get full text